- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03002987
Active Pregnancy Policy at Work. Greater Wellbeing and Lower Sickness Absence (AGp)
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Background: The majority of Danish women work during their reproductive years. Sickness absence among pregnant women is frequent; more than one third of Danish women are on longterm sick leave during pregnancy. Sick leave has been found associated with occupational exposures and studies have shown that adjustment in exposure can reduce sick leave in pregnancy indicating that there are potential preventive initiatives.
Design and outcomes: In a cluster randomized design it will be investigated whether teaching local leaders how to implement active pregnancy policy results in less sickness absence among their pregnant employees. It will further be investigated to what extent Active pregnancy policy is implemented at the departments and whether it results in higher sense of security and wellbeing among the pregnant employee. Finally the cost and benefits of the intervention will be analyzed.
The study takes place at hospitals in the two regions on Zealand, Denmark (The Capital region of Denmark and Region Zealand) and in the daycare sector in 2 municipalities located in The Capital region of Denmark. The randomization will be at the level of departments, which will be randomized to either intervention or control:
Intervention: The leaders are invited to a 3 hours seminar, where they will be taught in how to implement active pregnancy policy at their department.
Control: as usual
All employees at the involved departments getting pregnant during the year of intervention will be included in the study. They are to answer a questionnaire at 28th week of gestation and their days of sick leave during pregnancy will be recorded. All leaders at the departments are to answer two questionnaires, one before randomization and one after intervention.
The intervention: At the 3 hours seminar the leaders will receive education containing: 1) Updates on evidence on pregnancy and risk of occupational exposures, 2) information about the rules in the area and the leader's responsibilities, 3) Answers and solutions to frequent issues relating pregnant employees at work and 4) Introduction to Active Pregnancy policy.
The content of Active Pregnancy Policy: A congratulation letter to the pregnant employee inviting her to a meeting. At the meeting her job task will be discussed and fears and worries taken hand on. The aim is to adjust the job tasks to the employee and her special need during her pregnancy. During the pregnancy the leader regularly evaluate with the pregnant employee on how it goes and if there are needs for other or further adjustments. A minimum of 3 planned meetings have to be held during the pregnancy. Further the leader shall inform the other employees at the workplace about the arrangements made with the pregnant employee.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Copenhagen, Denemarken, 2400
- Department of occupational and evironmental medicine
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- pregnancy during intervention period, employed at one of the included departments/workplaces
Exclusion Criteria:
- not being able to understand, write and read Danish
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Intervention, education
Education of leaders (3 hours) in how to implement Active Pregnancy policy at their departements/workplaces
|
Education (3 hours) of leaders in how to implement Active pregnancy policy at their departments/work places
|
|
Geen tussenkomst: control
as usual
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
pregnancy related sick leave
Tijdsspanne: one year (intervention period)
|
difference in pregnancy related sick leave between the two randomized groups.
In days and the proportion of pregnant employee with longterm sick leave (> 4 weeks)
|
one year (intervention period)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To what extent Active pregnancy policy is implemented at the departments/workplaces
Tijdsspanne: one year (intervention period)
|
Difference between the two randomized groups in relation to the proportion of pregnant employees who experienced active pregnancy policy (different parts: Received congratulation letter, had scheduled meetings discussing the possible occupational exposures, adjustment of work tasks)
|
one year (intervention period)
|
|
Wether active pregnancy policy lead to higher sense of security and wellbeing among the pregnant employees
Tijdsspanne: one year
|
Difference between the two randomized groups in relation to the experience of security and wellbeing among the pregnant employees.
Using the WHO-5 and variables concerning the psychosocial work environment
|
one year
|
|
cost effectiveness of the intervention
Tijdsspanne: one year
|
calculating the costs of the intervention: 1)Holding the seminars (place, salary for teachers, food supply etc.) 2) time used (the leaders salary) attending the seminars, 3) Teaching material and the cost of resources used at the departments (control vs. intervention): 1) time used hiring temporary employees, 2) time used talking with pregnant employees, 3) time used changing the work tasks of the pregnant employee, 4) Salary to hired temporary employees.
|
one year
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Luise Moelenberg Begtrup, MD, Department of occupational Medicine, Bipspebjerg Hospital
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- AGp2016
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Active Pregnancy policy
-
Maastricht University Medical CenterB. Braun/Aesculap SpineVoltooidVerplaatsing van de tussenwervelschijf | DiskectomieNederland
-
Universidad Complutense de MadridOnbekendAtletische prestatieSpanje
-
Virginia Commonwealth UniversitySigma Theta Tau International Honor Society of Nursing; Southern Nursing Research...Voltooid
-
Aesculap Implant SystemsVoltooidDegeneratieve schijfziekteVerenigde Staten
-
RTI InternationalSetshaba Research CentreVoltooidHIV-preventieZuid-Afrika
-
RTI InternationalNational Institute of Mental Health (NIMH); SisterLove, Inc.; Positive Impact Health...Nog niet aan het wervenStoornis in het gebruik van middelen | Psychische stoornis | Implementatie Wetenschap | StigmatiseringVerenigde Staten
-
Duke UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); University of Chicago en andere medewerkersActief, niet wervendSystemische lupus erythematosus | AnticonceptieVerenigde Staten